| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.0M | +9.9% |
| Cost of Revenue | $69.5M | +3.3% |
| R&D Expense | $4.0M | +22.7% |
| SG&A Expense | $28.7M | -15.8% |
| Operating Income | -$2.0M | +85.3% |
| Pre-tax Income | -$5.3M | +56.4% |
| Income Tax | -$164K | -207.2% |
| Net Income | -$5.1M | +58.3% |
| EPS (Basic) | -$0.14 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -70.2% |
| Accounts Receivable | $14.9M | -8.1% |
| Inventory | $19.3M | -1.9% |
| Current Assets | $52.4M | -39.4% |
| Total Assets | $284.4M | +20.7% |
| Current Liabilities | $44.7M | +93.7% |
| Long-term Debt | $25.1M | +9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.5M | +162.9% |
| Investing Cash Flow | -$85.1M | -198.1% |
| Financing Cash Flow | $42.7M | +86.3% |
| +66.7% |
| EPS (Diluted) | -$0.14 | +66.7% |
| Total Liabilities |
| $67.1M |
| +17.5% |
| Stockholders' Equity | $217.3M | +21.8% |